Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Non-animal models in dermatological research.

Dellambra E, Odorisio T, D'Arcangelo D, Failla CM, Facchiano A.

ALTEX. 2018 Nov 19. doi: 10.14573/altex.1808022. [Epub ahead of print]

2.

Eosin treatment for psoriasis reduces skin leukocyte infiltration and secretion of inflammatory chemokines and angiogenic factors.

Capriotti L, Didona B, Madonna S, Scarponi C, Pilla MA, Facchiano F, Cordella M, Cavani A, Failla CM.

Eur J Dermatol. 2018 Aug 1;28(4):457-466. doi: 10.1684/ejd.2018.3357.

PMID:
30129532
3.

Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1.

Failla CM, Carbo M, Morea V.

Int J Mol Sci. 2018 Apr 27;19(5). pii: E1306. doi: 10.3390/ijms19051306. Review.

4.

Mice over-expressing placenta growth factor in the skin exhibit increased vascularization and vessel permeability independently of VEGF-A.

Failla CM, De Luca N, Zaccaria ML, De Domenico E, Avitabile S, Tatangelo L, Rossiter H, Tschachler E, Odorisio T.

J Dermatol Sci. 2018 Apr;90(1):93-96. doi: 10.1016/j.jdermsci.2017.12.015. Epub 2017 Dec 30. No abstract available.

PMID:
29366525
5.

Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding.

Graziani G, Ruffini F, Tentori L, Scimeca M, Dorio AS, Atzori MG, Failla CM, Morea V, Bonanno E, D'Atri S, Lacal PM.

Oncotarget. 2016 Nov 8;7(45):72868-72885. doi: 10.18632/oncotarget.12108.

6.

In Vivo Targeting of Cutaneous Melanoma Using an Melanoma Stimulating Hormone-Engineered Human Protein Cage with Fluorophore and Magnetic Resonance Imaging Tracers.

Vannucci L, Falvo E, Failla CM, Carbo M, Fornara M, Canese R, Cecchetti S, Rajsiglova L, Stakheev D, Krizan J, Boffi A, Carpinelli G, Morea V, Ceci P.

J Biomed Nanotechnol. 2015 Jan;11(1):81-92.

PMID:
26301302
7.

Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer.

Nardinocchi L, Sonego G, Passarelli F, Avitabile S, Scarponi C, Failla CM, Simoni S, Albanesi C, Cavani A.

Eur J Immunol. 2015 Mar;45(3):922-31. doi: 10.1002/eji.201445052. Epub 2015 Jan 16.

8.

Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype.

Orecchia A, Mettouchi A, Uva P, Simon GC, Arcelli D, Avitabile S, Ragone G, Meneguzzi G, Pfenninger KH, Zambruno G, Failla CM.

FASEB J. 2014 Feb;28(2):692-704. doi: 10.1096/fj.12-225771. Epub 2013 Oct 30.

PMID:
24174428
9.

Skin equivalents: a tool for the discovery and validation of pharmacodynamic biomarkers.

Paolini C, Orecchia A, Failla CM, Gallinari P, Zambruno G, Steinkühler C.

Cancer Invest. 2013 Jan;31(1):60-6. doi: 10.3109/07357907.2012.749269.

PMID:
23327193
10.

Expression of vascular endothelial growth factor-C in primary cutaneous melanoma predicts sentinel lymph node positivity.

Cianfarani F, Mastroeni S, Odorisio T, Passarelli F, Cattani C, Mannooranparampil TJ, Fortes C, Failla CM.

J Cutan Pathol. 2012 Sep;39(9):826-34. doi: 10.1111/j.1600-0560.2012.01955.x. Epub 2012 Jul 16.

PMID:
22804631
11.

Sirtinol treatment reduces inflammation in human dermal microvascular endothelial cells.

Orecchia A, Scarponi C, Di Felice F, Cesarini E, Avitabile S, Mai A, Mauro ML, Sirri V, Zambruno G, Albanesi C, Camilloni G, Failla CM.

PLoS One. 2011;6(9):e24307. doi: 10.1371/journal.pone.0024307. Epub 2011 Sep 12. Erratum in: PLoS One. 2011;6(10). doi:10.1371/annotation/0174b439-c62b-42e8-a420-3defbfe5c8e9.

12.

Expression of the soluble vascular endothelial growth factor receptor-1 in cutaneous melanoma: role in tumour progression.

Ruffini F, Failla CM, Orecchia A, Bani MR, Dorio AS, Fortes C, Zambruno G, Graziani G, Giavazzi R, D'Atri S, Lacal PM.

Br J Dermatol. 2011 May;164(5):1061-70. doi: 10.1111/j.1365-2133.2010.10200.x.

PMID:
21198538
13.

STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation.

Sestito R, Madonna S, Scarponi C, Cianfarani F, Failla CM, Cavani A, Girolomoni G, Albanesi C.

FASEB J. 2011 Mar;25(3):916-27. doi: 10.1096/fj.10-172288. Epub 2010 Nov 23.

PMID:
21098725
14.

Inhibition of endothelial cell migration and angiogenesis by a vascular endothelial growth factor receptor-1 derived peptide.

Lacal PM, Morea V, Ruffini F, Orecchia A, Dorio AS, Failla CM, Soro S, Tentori L, Zambruno G, Graziani G, Tramontano A, D'Atri S.

Eur J Cancer. 2008 Sep;44(13):1914-21. doi: 10.1016/j.ejca.2008.06.032. Epub 2008 Aug 3.

PMID:
18682321
15.

A proangiogenic peptide derived from vascular endothelial growth factor receptor-1 acts through alpha5beta1 integrin.

Soro S, Orecchia A, Morbidelli L, Lacal PM, Morea V, Ballmer-Hofer K, Ruffini F, Ziche M, D'Atri S, Zambruno G, Tramontano A, Failla CM.

Blood. 2008 Apr 1;111(7):3479-88. doi: 10.1182/blood-2007-03-077537. Epub 2008 Jan 9.

16.

Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential.

Cianfarani F, Zambruno G, Brogelli L, Sera F, Lacal PM, Pesce M, Capogrossi MC, Failla CM, Napolitano M, Odorisio T.

Am J Pathol. 2006 Oct;169(4):1167-82.

17.

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

Marcellini M, De Luca N, Riccioni T, Ciucci A, Orecchia A, Lacal PM, Ruffini F, Pesce M, Cianfarani F, Zambruno G, Orlandi A, Failla CM.

Am J Pathol. 2006 Aug;169(2):643-54.

18.

Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed.

Cianfarani F, Tommasi R, Failla CM, Viviano MT, Annessi G, Papi M, Zambruno G, Odorisio T.

Br J Dermatol. 2006 Jan;154(1):34-41.

PMID:
16403091
19.

The placenta growth factor in skin angiogenesis.

Odorisio T, Cianfarani F, Failla CM, Zambruno G.

J Dermatol Sci. 2006 Jan;41(1):11-9. Epub 2005 Oct 10. Review. Erratum in: J Dermatol Sci. 2004 Jul;43(1):71.

PMID:
16216466
20.

Expression and function of neurotrophins and their receptors in cultured human keratinocytes.

Marconi A, Terracina M, Fila C, Franchi J, Bonté F, Romagnoli G, Maurelli R, Failla CM, Dumas M, Pincelli C.

J Invest Dermatol. 2003 Dec;121(6):1515-21. Erratum in: J Invest Dermatol. 2004 Oct;123(4):803.

21.

Integrin alpha3beta1 is an alternative cellular receptor for adenovirus serotype 5.

Salone B, Martina Y, Piersanti S, Cundari E, Cherubini G, Franqueville L, Failla CM, Boulanger P, Saggio I.

J Virol. 2003 Dec;77(24):13448-54.

22.

Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.

Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, Failla CM, Zambruno G.

Cancer. 2003 Aug 15;98(4):789-97.

23.

Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the alpha 5 beta 1 integrin.

Orecchia A, Lacal PM, Schietroma C, Morea V, Zambruno G, Failla CM.

J Cell Sci. 2003 Sep 1;116(Pt 17):3479-89. Epub 2003 Jul 15.

24.

Molecular control of physiological skin angiogenesis.

Odorisio T, Failla CM, Zambruno G.

Eur J Dermatol. 2002 Nov-Dec;12(6):VII-X. Review. No abstract available.

PMID:
12506892
25.

Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.

Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, Failla CM, Zambruno G.

J Cell Sci. 2002 Jun 15;115(Pt 12):2559-67.

26.

Binding properties, cell delivery, and gene transfer of adenoviral penton base displaying bacteriophage.

Di Giovine M, Salone B, Martina Y, Amati V, Zambruno G, Cundari E, Failla CM, Saggio I.

Virology. 2001 Mar 30;282(1):102-12.

27.

Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor.

Lacal PM, Failla CM, Pagani E, Odorisio T, Schietroma C, Falcinelli S, Zambruno G, D'Atri S.

J Invest Dermatol. 2000 Dec;115(6):1000-7.

28.

Placenta growth factor is induced in human keratinocytes during wound healing.

Failla CM, Odorisio T, Cianfarani F, Schietroma C, Puddu P, Zambruno G.

J Invest Dermatol. 2000 Sep;115(3):388-95.

29.

Autoimmunity of the dermal-epidermal junction.

Zambruno G, Failla CM.

Eur J Dermatol. 1999 Sep;9(6):437-42. Review. No abstract available.

PMID:
10491497
30.

Redesigning the substrate specificity of the hepatitis C virus NS3 protease.

Failla CM, Pizzi E, De Francesco R, Tramontano A.

Fold Des. 1996;1(1):35-42.

PMID:
9079362
31.

Redesigning the substrate specificity of the hepatitis C virus NS3 protease.

Failla CM, Pizzi E, Francesco RD, Tramontano A.

Fold Des. 1995;1(1):35-42.

PMID:
9162139

Supplemental Content

Loading ...
Support Center